Maya Matthews to Discuss EU Health Technology Assessment Regulation at ESMO 2025

October 20, 2025 - 03:38

Maya Matthews is set to present the EU Health Technology Assessment (HTA) Regulation at the upcoming European Society for Medical Oncology (ESMO) 2025 conference. This significant event will bring together experts, researchers, and healthcare professionals to discuss advancements in cancer treatment and policy.

The EU HTA Regulation aims to streamline the assessment process for new health technologies across Europe, ensuring that patients have timely access to innovative therapies. Matthews, a prominent advocate for cancer patients, will highlight the importance of this regulation in improving healthcare outcomes and ensuring that treatments are both effective and accessible.

As cancer continues to be a leading cause of mortality worldwide, the discussions at ESMO 2025 will be crucial in shaping future policies. Matthews' insights are expected to resonate with attendees, emphasizing the need for collaboration among stakeholders to enhance patient care and support the integration of new technologies into clinical practice. The conference promises to be a vital platform for advancing the conversation on cancer treatment and health technology assessment in Europe.